US Warehouse Peptide Powder Lyophilized Powder 10 mg peptides
TDS
597562-32-8
Pharmaceutical Grade
99.9%
TIANJIN
kaifeng
by box
2025-12-31
peptide product
-
Product Description
-
Seller Information
-
DescriptionCertificates
-
TDS
Basic Info-
Product Name:
ANTIBACTERIAL PROTEIN LL-37 AMIDE (HUMAN)
Other Name:LL-37;ANTIBACTERIAL PROTEIN LL-37 AMIDE (HUMAN);H-LEU-LEU-GLY-ASP-PHE-PHE-ARG-LYS-SER-LYS-GLU-LYS-ILE-GLY-LYS-GLU-PHE-LYS-ARG-ILE-VAL-GLN-ARG-ILE-LYS-ASP-PHE-LEU-ARG-ASN-LEU-VAL-PRO-ARG-THR-GLU-SER-NH2;LL-37Antibacterial Protein LL-37 aMide (huMan), LL37, CAMP;Antibacterial Protein LL-37 aMide (huMan), CAMP, LL37;LL-37 aMide;Anti-CAMP (66-80) antibody produced in rabbit;Anti-CAMP Cathelicidin anti-microbial peptide precursor
CAS No.:597562-32-8
Molecular Formula:C205H341N61O52
InChIKeys:JATXYCFPJFQHBQ-XAMSXPGMSA-N
Molecular Weight:4492.27854
Exact Mass:4491.598
Categories:
Characteristics-
PSA:
1910
XLogP3:-19
Storage Conditions:-20°C
Research-
Class:
Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)
Status:Investigational — Phase 3 (REDEFINE program, CagriSema combination)
Mechanism:A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.
Activity note:Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.
Source:MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.
Clinical Development:
References-
PubChem:Literature:
MCE: Cagrilintide (CAS 1415456-99-3); ClinicalTrials.gov: REDEFINE-1 (NCT05249895); Novo Nordisk: EASD 2025 Cagrilintide data presentation
Disclaimer:Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
peptide product
-
Location:
Binhai High-tech Zone
-
Payment Terms:
TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
2
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
201-300
-
Year of Establishment:
2025
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
- Hot Searches
- phosphoric acid powder
- reta weight loss where to buy
- fenbendazole and ivermectin for sale
- retatrutide glp-3 for sale
- methanol price
- conductive silicone rubber market
- crude oil prices this morning
- bioglutide buy online
- piperazine
- potassium chloride price
- ethyl bromide
- dipotassium phosphate for food market